Skip to content

Role of pippalyadi anjana And Triphala Rasayana in first stage of cataract

Role Of Pippalyadi Anjana And Triphala Rasayana in Timira(Immature Senile Cataract)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024668
Enrollment
40
Registered
2020-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: H259- Unspecified age-related cataract

Interventions

Intervention1: Pippalyadi anjana and Triphala Rasayana: First deepen pachana (3-7days)according to the koshth of patient.Then topical application of pippalyadi anjana in the form of ointment into the

Sponsors

Rishikul campus UAU Harrawala Dehradun
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.6/9-6/60 with best corrected visual acuity. 2.patient having sign and symptoms of pratham,dwitiya and tritiya patalagata timira 3.Stage of immature cataract

Exclusion criteria

Exclusion criteria: 1.patient less than 45 years and more than 70 years. 2.Less than 6/60 with best corrected visual acuity. 3.patient having signs and symptoms of mature and hyper mature cataract. 4.Known case of congenital,developmental,traumatic,complicated and metabolic cataract. 5.patient associated with Hypertension and diabetes mellitus. 6.patient under chemotherapy, steroids and immunosuppressive drugs therapy 7.known case of uvietis,glaucoma and retinopathies.

Design outcomes

Primary

MeasureTime frame
Delay the progression of senile cataractTimepoint: 2 months

Secondary

MeasureTime frame
Relief in the associated symptoms of senile cataractTimepoint: 2 months

Countries

India

Contacts

Public ContactDr Gunjan Sharma

Uttrakhand ayurved university, Harrawala Dehradun

gunjan06purity@gmail.com8218428029

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026